» Articles » PMID: 39344546

Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment

Overview
Journal Korean J Radiol
Specialty Radiology
Date 2024 Sep 30
PMID 39344546
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) progresses through multiple stages of hepatocarcinogenesis, with each stage characterized by specific changes in vascular supply, drainage, and microvascular structure. These vascular changes significantly influence the imaging findings of HCC, enabling non-invasive diagnosis. Vascular changes in HCC are closely related to aggressive histological characteristics and treatment responses. Venous drainage from the tumor toward the portal vein in the surrounding liver facilitates vascular invasion, and the unique microvascular pattern of vessels that encapsulate the tumor cluster (known as a VETC pattern) promotes vascular invasion and metastasis. Systemic treatments for HCC, which are increasingly being used, primarily target angiogenesis and immune checkpoint pathways, which are closely intertwined. By understanding the complex relationship between histopathological vascular changes in hepatocarcinogenesis and their implications for imaging findings, radiologists can enhance the accuracy of imaging diagnosis and improve the prediction of prognosis and treatment response. This, in turn, will ultimately lead to better patient care.

Citing Articles

Construction of nomogram model based on contrast-enhanced ultrasound parameters to predict the degree of pathological differentiation of hepatocellular carcinoma.

Lian S, Cheng H, Li H, Wang H Front Oncol. 2025; 15:1519703.

PMID: 39931079 PMC: 11807825. DOI: 10.3389/fonc.2025.1519703.

References
1.
Fang J, Xu L, Shang L, Pan C, Ding J, Tang Y . Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma. Hepatology. 2018; 70(3):824-839. DOI: 10.1002/hep.30366. View

2.
Park J, Park Y, Kim M, Park M, Choi J, Chung Y . Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics. Liver Int. 2023; 43(6):1332-1344. DOI: 10.1111/liv.15589. View

3.
Vanderborght B, Lefere S, Van Vlierberghe H, Devisscher L . The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma. Cells. 2020; 9(11). PMC: 7693961. DOI: 10.3390/cells9112382. View

4.
Calderaro J, Meunier L, Nguyen C, Boubaya M, Caruso S, Luciani A . ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma. Clin Cancer Res. 2019; 25(19):5859-5865. DOI: 10.1158/1078-0432.CCR-19-0859. View

5.
Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M . Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000; 33(2):282-9. DOI: 10.1016/s0168-8278(00)80369-4. View